Schwab US Large Cap Growth ETF vs Synopsys, Inc. — how do they compare? Schwab US Large Cap Growth ETF trades at $36.7 (market cap $65.01B), while Synopsys, Inc. trades at $502.54 (market cap $95.39B). The key difference: Synopsys, Inc. is the larger of the two by market cap, and Schwab US Large Cap Growth ETF is trading nearer its 52-week high, Synopsys, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Schwab US Large Cap Growth ETF for 50 Days and Synopsys, Inc. for 71 Days on average.
| SCHG | SNPS | |
|---|---|---|
Market Cap | $65.01B | $95.39B |
Volume | 8,554,399 | 3,374,903 |
Sector | Sector/Thematic | Technology |
52-Week High | $36.93 | $534.56 |
52-Week Low | $28.10 | $367.70 |
Typical Hold Time | 50 Days | 71 Days |
Enterprise Value | — | $102.62B |
Signals from Pluang's Aura AI — not financial advice
SCHG trades at $36.87, down slightly by 0.16% today, with technical indicators showing a bullish moving average trend but overbought RSI signals. The ETF maintains strong institutional interest despite recent position adjustments by some wealth managers. Recent media coverage highlights SCHG's low-cost growth exposure and historical performance advantages over broader market indices.
The outlook remains positive given SCHG's focus on large-cap growth stocks and competitive expense ratio, though concentration risk in top holdings and potential market volatility present challenges. Long-term growth prospects appear favorable based on historical returns and continued investor appetite for growth-oriented strategies.
Synopsys (SNPS) trades at $502.67, down 0.49% on the day, but maintains strong bullish momentum with recent AI-driven partnerships and earnings beats. The stock shows robust fundamentals with Q2 2026 EPS of $3.91 beating expectations by 6.5%, supported by a 72.38% gross margin. Technical indicators show bullish moving averages but overbought RSI levels above 89, with key support at $500 and resistance at $505. Recent announcements with OpenAI and Amazon have driven significant investor optimism and price target upgrades.
The outlook remains positive with 93% analyst buy ratings and a $572.54 consensus target suggesting 14% upside. Key opportunities include AI-driven chip design growth and Ansys integration synergies, while risks include high valuation (P/E 87.7) and execution challenges in large-scale partnerships. The stock's proximity to all-time highs requires careful monitoring of earnings delivery and competitive pressures in the EDA market.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
SCHG is an ETF that seeks to track the total return of the Dow Jones U.S. Large-Cap Growth Total Stock Market Index. The fund provides low-cost exposure to a diversified portfolio of large-capitalization U.S. companies that are classified as growth stocks based on factors such as sales, earnings, and book value growth rates. SCHG is often used by investors seeking long-term capital appreciation from market-leading companies with above-average growth potential.
Read more on SCHG →Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Read more on SNPS →